SciSparc Ltd. Made Headway
Wed, Sep 14, 2022 at 07:33 PM
SciSparc Ltd. (SPRC:NASDAQ) rocketted at $0.97, representing a gain of 23.9%. On Wed, Sep 14, 2022, SPRC:NASDAQ hit a New 2-Week High of $0.97. The stock appeared on our News Catalysts scanner on Wed, Sep 14, 2022 at 07:54 AM in the 'AGREEMENT' category. From Wed, Aug 31, 2022, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Wed, Sep 14, 2022 at $1.45 with a volume of 91M+.
About SciSparc Ltd. (SPRC:NASDAQ)
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field.
Top 10 Gainers:
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 311.78%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 53.2%
- AMTD International Inc. American Depositary Shares each representing one Class A (AMTD:NYSE), 50%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 42.21%
- Dawson Geophysical Company (DWSN:NASDAQ), 40.18%
- Akerna Corp. (KERN:NASDAQ), 26.92%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 24.4%
- SciSparc Ltd. (SPRC:NASDAQ), 23.89%
- ZeroFox Holdings Inc. (ZFOX:NASDAQ), 22.9%
- Magic Empire Global Limited (MEGL:NASDAQ), 21.51%